Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1166 ARTÍCULOS , VIENDO DEL 391 AL 405

Alzheimer's Disease: Mechanism and Approach to Cell Therapy

Amemori T, Jendelova P, Ruzicka J, Urdzikova LM, Sykova E.

Int J Mol Sci. 2015 Nov 4;16(11):26417-51. doi: 10.3390/ijms161125961.

ASM in Alzheimer's disease

Lee JK, Jin HK, Bae JS.

Oncotarget. 2015 Nov 24;6(37):39389-90. doi: 10.18632/oncotarget.6333.

The Special Topics Section of Alzheimer's & Dementia

Khachaturian ZS, Mesulam MM, Khachaturian AS, Mohs RC.

Alzheimers Dement. 2015 Nov;11(11):1261-4. doi: 10.1016/j.jalz.2015.10.002.

Calcium/calmodulin-dependent kinase II and Alzheimer's disease

Ghosh A, Giese KP.

Mol Brain. 2015 Nov 24;8(1):78. doi: 10.1186/s13041-015-0166-2.

Basic aspects in selecting a suitable transgenic rodent model for Alzheimer's disease

Balmus IM, Ciobica A, Negura A, Negura L, Anton E.

Psychiatr Danub. 2015 Dec;27(4):338-45.

Current and Future Treatments for Alzheimer Disease

Small GW, Greenfield S.

Am J Geriatr Psychiatry. 2015 Nov;23(11):1101-5. doi: 10.1016/j.jagp.2015.08.006. Epub 2015 Sep 9.

Real-world evaluation of compliance and preference in Alzheimer's disease treatment

Pai MC, Aref H, Bassil N, Kandiah N, Lee JH, Srinivasan AV, diTommaso S, Yuksel O.

Clin Interv Aging. 2015 Nov 3;10:1779-87. doi: 10.2147/CIA.S85319. eCollection 2015.

Comparison of qualitative and quantitative imaging characteristics of [11C]PiB and [18F]flutemetamol in normal control and Alzheimer's subjects

Mountz JM, Laymon CM, Cohen AD, Zhang Z, Price JC, Boudhar S, McDade E, Aizenstein HJ, Klunk WE, Mathis CA.

Neuroimage Clin. 2015 Oct 14;9:592-8. doi: 10.1016/j.nicl.2015.10.007. eCollection 2015.

Herbal medicine Davaie Loban in mild to moderate Alzheimer's disease: A 12-week randomized double-blind placebo-controlled clinical trial

Tajadini H, Saifadini R, Choopani R, Mehrabani M, Kamalinejad M, Haghdoost AA.

Complement Ther Med. 2015 Dec;23(6):767-72. doi: 10.1016/j.ctim.2015.06.009. Epub 2015 Aug 29.

Cholinesterase inhibitor discontinuation in patients with Alzheimer's disease: a meta-analysis of randomized controlled trials

O'Regan J, Lanctôt KL, Mazereeuw G, Herrmann N.

J Clin Psychiatry. 2015 Nov;76(11):e1424-31. doi: 10.4088/JCP.14r09237.

Molecular Targets in Alzheimer's Disease: From Pathogenesis to Therapeutics

Cheng X, Zhang L, Lian YJ.

Biomed Res Int. 2015;2015:760758. doi: 10.1155/2015/760758. Epub 2015 Nov 19.

ACAT1/SOAT1 as a therapeutic target for Alzheimer's disease

Shibuya Y, Chang CC, Chang TY.

Future Med Chem. 2015;7(18):2451-67. doi: 10.4155/fmc.15.161. Epub 2015 Dec 15.

Cyclooxygenase-2 gene polymorphisms and risk of Alzheimer's disease: A meta-analysis

Luo D, Long Y, Chen GJ.

J Neurol Sci. 2015 Dec 15;359(1-2):100-5. doi: 10.1016/j.jns.2015.10.053. Epub 2015 Oct 30.

[Coordinated care is paying off]

Rex C, Meier AG, Bischofberger I.

Krankenpfl Soins Infirm. 2015;108(7):14-6.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias